✦ LIBER ✦

Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis

✍ Scribed by Virginie Woerly; Laurence Maynard; Annaële Sanquer; Hyone-Myong Eun

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 140 KB
Volume: 105
Category: Article
ISSN: 1432-1955
DOI: 10.1007/s00436-009-1404-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative study on the short term effi

Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis

✍ Marta Mateo; Laurence Maynard; Claudia Vischer; Paolo Bianciardi; Guadalupe Miró 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 160 KB

Clinical efficacy of two different drug

Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis

✍ M. G. Pennisi; S. Lo Giudice; M. Masucci; M. De Majo; S. Reale; F. Vitale 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 64 KB

Comparison of BNCT and GdNCT efficacy in

Comparison of BNCT and GdNCT efficacy in treatment of canine cancer

✍ V.N. Mitin; V.N. Kulakov; V.F. Khokhlov; I.N. Sheino; A.M. Arnopolskaya; N.G. Ko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 296 KB

The efficacy and tolerability of long-te

The efficacy and tolerability of long-term felodipine treatment in hypertension

✍ H. Borgmästars; B. Forsén; J. Tuomilehto; R. Hellebø; P. O. Walle; H. M. Nielsen 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 612 KB

Efficacy and tolerability of sumatriptan

Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks

✍ G. Bussone; G.C. Manzoni; P. Cortelli; M. Roncolato; L. Fabbri; C. Benassuti 📂 Article 📅 2000 🏛 Springer Milan 🌐 English ⚖ 55 KB

Efficacy and tolerability of vindesine i

Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer

✍ D. A. L. Morgan 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 134 KB

Eighteen patients suffering from small-cell lung cancer, all with measurable lesions, were treated with vindesine (3 mg/m2 i.v. on days 1 and 8 of a 21-day cycle). Partial responses (PR) were seen in six patients (three of whom had been previously heavily treated). Most patients tolerated the drug e